Skip to main content
HairCited

Innovation in Alopecia Areata.

Luiza Kalil, Brett King
Review Dermatologic clinics 2025 5 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D39542562'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Patients with alopecia areata (review)
Intervention
Innovation in Alopecia Areata. None
Vergleichsgruppe
None
Primärer Endpunkt
Alopecia areata treatment outcomes
Wirkungsrichtung
Positive
Verzerrungsrisiko
Unclear

Abstract

Advances in understanding of AA have led to the first approved therapies for this disease, and in the past two years, there have been three medicines approved for the treatment of severe alopecia areata. There are numerous clinical trials of novel therapeutics underway across the spectrum of AA.

Zusammenfassung

None

Used In Evidence Reviews

Similar Papers